Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Polymorphisms in ion channel genes: emerging roles in pain.

Waxman SG.

Brain. 2010 Sep;133(9):2515-8. doi: 10.1093/brain/awq240. No abstract available.

PMID:
20802201
2.

Genetic polymorphisms and idiopathic generalized epilepsies.

Lucarini N, Verrotti A, Napolioni V, Bosco G, Curatolo P.

Pediatr Neurol. 2007 Sep;37(3):157-64. Review.

PMID:
17765802
3.

Approaches to cloning of pain-related ion channel genes.

Akopian AN.

Methods Mol Biol. 2013;998:3-19. doi: 10.1007/978-1-62703-351-0_1. Review.

PMID:
23529417
4.

Glycinergic transmission.

Kirsch J.

Cell Tissue Res. 2006 Nov;326(2):535-40. Review.

PMID:
16807723
5.

Fishing for genes: practical ways to study genetic polymorphisms for pain.

Eisenach JC.

Anesthesiology. 2004 Jun;100(6):1343-4. No abstract available.

PMID:
15166551
6.
7.

Bioinformatic analysis of human CNS-expressed ion channels as candidates for episodic nervous system disorders.

Freudenberg J, Fu YH, Ptácek LJ.

Neurogenetics. 2007 Aug;8(3):159-68.

PMID:
17333079
8.

H(+)-gated cation channels: neuronal acid sensors in the NaC/DEG family of ion channels.

Waldmann R, Lazdunski M.

Curr Opin Neurobiol. 1998 Jun;8(3):418-24. Review.

PMID:
9687356
10.

Transcriptional channelopathies: an emerging class of disorders.

Waxman SG.

Nat Rev Neurosci. 2001 Sep;2(9):652-9. Review. No abstract available.

PMID:
11533733
11.

From molecule to malady.

Ashcroft FM.

Nature. 2006 Mar 23;440(7083):440-7. Review.

PMID:
16554803
12.

Affect of genetic polymorphisms on pain perception and pain management in lung cancer survivors.

Kapoor S.

J Opioid Manag. 2012 May-Jun;8(3):142. doi: 10.5055/jom.2012.0108. No abstract available.

PMID:
22798172
13.

Comprehensive analysis of the ascidian genome reveals novel insights into the molecular evolution of ion channel genes.

Okamura Y, Nishino A, Murata Y, Nakajo K, Iwasaki H, Ohtsuka Y, Tanaka-Kunishima M, Takahashi N, Hara Y, Yoshida T, Nishida M, Okado H, Watari H, Meinertzhagen IA, Satoh N, Takahashi K, Satou Y, Okada Y, Mori Y.

Physiol Genomics. 2005 Aug 11;22(3):269-82.

14.

Pain as a channelopathy.

Raouf R, Quick K, Wood JN.

J Clin Invest. 2010 Nov;120(11):3745-52. doi: 10.1172/JCI43158. Review.

15.

High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.

Dunlop J, Bowlby M, Peri R, Vasilyev D, Arias R.

Nat Rev Drug Discov. 2008 Apr;7(4):358-68. doi: 10.1038/nrd2552. Review.

PMID:
18356919
16.

Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain.

Birch PJ, Dekker LV, James IF, Southan A, Cronk D.

Drug Discov Today. 2004 May 1;9(9):410-8. Review.

PMID:
15081958
17.

[Clinical aspects of epileptic ion channel disorders].

Campos-Castelló J, Canelón de López M, García-Fernández M.

Rev Neurol. 2000 Jun;30 Suppl 1:S42-6. Review. Spanish.

PMID:
10904967
18.

Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size.

Belfer I, Wu T, Kingman A, Krishnaraju RK, Goldman D, Max MB.

Anesthesiology. 2004 Jun;100(6):1562-72. No abstract available.

PMID:
15166579
19.

Neurological diseases caused by ion-channel mutations.

Weinreich F, Jentsch TJ.

Curr Opin Neurobiol. 2000 Jun;10(3):409-15. Review.

PMID:
10851168
20.

Is there genetic polymorphism evidence for individual human sensitivity to opiates?

Nagashima M, Katoh R, Sato Y, Tagami M, Kasai S, Ikeda K.

Curr Pain Headache Rep. 2007 Apr;11(2):115-23. Review.

PMID:
17367590

Supplemental Content

Support Center